Skip to content

Evaluation of exfoliated tumor cells after spcimen collection for pathology.

Evaluation of exfoliated tumor cells after spcimen collection for pathology. - Evaluation of exfoliated tumor cells after spcimen collection.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000034189
Enrollment
30
Registered
2018-09-18
Start date
2018-09-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Submucosal tumor

Interventions

None listed

Sponsors

kyushu univercity hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with SMT who undergo EUS-FNA or endoscopic mucosal incision assisted biopsy (MIAB), and collected gastri juice. 2. Patients from whom written informed consent is obtained. 3. Patients who are older than 20 years old.

Exclusion criteria

Exclusion criteria: 1. Patients who are judged as contraindication for EUS-FNA or MIAB. 2. Patients who are judged as being inappropriate for this study by their medical doctor.

Design outcomes

Primary

MeasureTime frame
The percentage of the exfoliated tumor cells.

Countries

Japan

Contacts

Public ContactYosuke Minoda

Kyushu University Graduate School of Medical Sciences Department of Medicine and Bioregulatory Science

yminoda@med.kyushu-u.ac.jp0926425082

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026